Company Overview of Celgene Avilomics Research, Inc.
Celgene Avilomics Research, Inc., a clinical-stage biotechnology company, focuses on the design and development of targeted covalent drugs. Its product candidate CC-292, a treatment for cancer and autoimmune diseases is in phase I clinical testing. Celgene Avilomics Research, Inc. was formerly known as Avila Therapeutics, Inc. and changed its name to Celgene Avilomics Research, Inc. in June 2012. The company was incorporated in 2006 and is based in Waltham, Massachusetts. As of March 7, 2012, Celgene Avilomics Research, Inc. operates as a subsidiary of Celgene Corporation.
100 Beaver Street
Waltham, MA 02453-8425
Founded in 2006
Key Executives for Celgene Avilomics Research, Inc.
Similar Private Companies By Industry
|Center for Biocatalysis and Bioprocessing||United States|
|Vitis Biosciences Inc.||United States|
|Vet Therapeutics, Inc.||United States|
|Stem Cell Innovations, Inc.||United States|
|Functional Genetics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Celgene Avilomics Research, Inc., please visit www.celgene.com/research-development/rd-locations/avilomics-research/. Company data is provided by Capital IQ. Please use this form to report any data issues.